Patents and Publications

Select a Category

Search

Pharmaceutical Composition for Treating Brain Diseases Comprising Antibody Specifically Binding to ASM Protein as Active Ingredient

Inventors Seung Beom Hong, Jae Sung BAE, Hee Kyung Jin Assignees ISU ABXIS Co Ltd, Industry Academic Cooperation Foundation of ...

Formation of Amyloid-Like Conformational States of β-Structured Membrane Proteins on the Example of OMPF Porin from the Yersinia pseudotuberculosis Outer Membrane

Authors Olga D. Novikova1, Tatyana V. Rybinskaya1, Elena A. Zelepuga1, Vladimir N. Uversky2, Nataliya Yu1. Kim, Ekaterina A. Chingizova1, Ekaterina ...

Trogocytosis Targeting Chimeras (TrogoTACs) for Targeted Protein Transfer

Authors Nicholas A. Till1,2, Muthukumar Ramanathan2,3, Kang Yong Loh1,2, and Carolyn R. Bertozzi1,2,4 Organizations Department of Chemistry, Stanford University, Stanford, ...

Synergistic Interactions for Improved Cancer Treatment

Inventors Barbara K. Felber, George N. Pavlakis, Sevasti KARALIOTA, Dimitrios STELLAS Assignees The United States Of America, As Represented By ...

Rapid Profiling of the Glycosylation Effects on the Binding of SARS-CoV-2 Spike Protein to Angiotensin-Converting Enzyme 2 Using MALDI-MS with High Mass Detection

Authors Yuye Zhou, Congrui Tan, Renato Zenobi Organizations Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), ...

Co-opting the E3 Ligase KLHDC2 for Targeted Protein Degradation by Small Molecules

Authors Christopher M. Hickey, Katherine M. Digianantonio, Kurt Zimmermann, Alicia Harbin, Connor Quinn, Avani Patel, Peter Gareiss, Amanda Chapman, Bernadette ...

Anti-BTN3A Antibodies For Use In Methods Of Treating Gastro-Intestinal Inflammatory Disorders

Inventors Sophie AGAUGUE, Paul Frohna Assignees Imcheck Therapeutics Abstract It is disclosed BTN3A inhibitory antibodies for use in treating ...

Prev
1
2
3
4
…
9
Next

text

Talk to Our Scientists

Our team is available to answer any of your questions about our products and services